CORAL SPRINGS, Fla.--(BUSINESS WIRE)--Dec. 15, 2000--P.D.C. Innovative Industries (OTCBB:PDCI) management announced Friday, after a meeting held with Clearlake Financial Corp., Hialeah, Fla., that Clearlake President, Ronald Epstein has agreed to direct the marketing traffic for the company's proprietary and recently completed (prototype) product, Hypo-Sterile 2000.Clearlake
is a nationwide independent leasing organization specializing in providing financial programs for the health care industry.The company purchases equipment with funds obtained from its institutional sources.Clearlake's offices are adjacent to The Tenet Hospital campus of The Palmetto Medical Center
began as a joint venture with The Pal-Med Medical Group
comprised even then of over 250 physicians in March 1993.Although now separated from the group because of the referral laws, Clearlake
remains in The Pal Med building for mutual business benefits, rapidly developing a reputation as one of the nation's leading independent financial services devoted to financing technology whose programs are designed specifically to expedite the selling process for vendors.Ronald Epstein has been the Clearlake Financial Corp. president since its inception in 1992, and has headed Clearlake Leasing Co. since 1986.
After a meeting with PDCI management
earlier this week and touring the company plant floor in Coral Springs, Epstein
stated, "We are convinced that the Hypo-Sterile 2000 was a product that could be marketed all over the world," and further stated that he
would accept taking a major roll in distribution of product as requested by PDCI management
.Apparently impressed with the market potential of the product, Clearlake management intends to associate with marketing partners and alliances who can penetrate the medical products industry.David Sowers, founder, and his management team issued a statement, "The addition of Ron Epstein and Clearlake Financial will be an absolute acceleration of market penetration and the extended contacts of Clearlake could make the Hypo-Sterile an immediate revenue success."
...Because of the relatively lower cost of the Sterile-Box (approximately $3,000 for the desktop model) as opposed to the monthly cost of removing contaminated product, Clearlake, through its president, Ron Epstein has offered to take an active roll in directing PDCI to medical product distributors and has informed PDCI management that his organization is already contacting certain industry associates.Although Clearlake, as a rule, does not enter into the marketing and distribution areas with client product, they have told PDCI that their involvement will include product representation because they consider the Sterile-Box 2000 to be unique as a sales vehicle, according to its president, Ron Epstein.